Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Elena Ainora"'
Autor:
F. Fiore, Antonio Gasbarrini, Veronica Ojetti, Maria Elena Ainora, Giovanni Gigante, Federico Barbaro
Publikováno v:
Digestive and Liver Disease Supplements. 3:35-39
The human intestine lodges a large amount of microorganisms, with over 500 species of bacteria whose density increases through the small bowel reaching concentrations from 10 9 to 10 14 colony-forming unit/ml in the colon. More than 99% of the gut mi
Autor:
Veronica Ojetti, Giovanni Gigante, G. Bruno, Gianluca Rizzo, Antonio Gasbarrini, Davide Roccarina, Maria Elena Ainora
Publikováno v:
Gastroenterology Research and Practice, Vol 2012 (2012)
Gastroenterology Research and Practice
Gastroenterology Research and Practice
Introduction.Helicobacter pylorieradication therapy has the potential burden of antibiotic-associated gastrointestinal (GI) side effects. The occurrence of side effects is among the major drawbacks of such regimens. GI manifestations may be related t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52f2a348dcfeb9e626615d9ed7f0b8f
http://hdl.handle.net/11573/1189951
http://hdl.handle.net/11573/1189951
Autor:
Antonio Gasbarrini, Ernesto Cristiano Lauritano, Maurizio Gabrielli, Veronica Ojetti, Alessio Migneco, Luigi Fontana, Maria Elena Ainora, Federico Barbaro
Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, with a low gastrointestinal absorption and a good antibacterial activity. The antibacterial action covers Gram-positive and Gram-negative organisms, both aerobes and anaerobes. It
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7303932ceee584122f114ddc4a93446a
http://hdl.handle.net/11379/305167
http://hdl.handle.net/11379/305167
Autor:
Alessio Migneco, Antonio Gasbarrini, Veronica Ojetti, Nicolò Gentiloni Silveri, Maurizio Gabrielli, Giovanni Gasbarrini, Maria Elena Ainora, Giovanni Gigante
Publikováno v:
Gastroenterology. 136:A-214